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Treatment Reponse
Conclusion: Consistent with published studies, SVR rates were
igher for genotypes 2 and 3 than genotype 1. RVR and EVR are
trong predictors for SVR. The actual dosages of ribavirin adminis-
eredandreceived, appears to correlatewith likelihoodof achieving
VR. Regular monitoring and followup is essential and recom-
ended.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.195
ype: Poster Presentation
inal Abstract Number: 40.034
ession: Virology and Viral Infections (Non-HIV)
ate: Thursday, June 14, 2012
ime: 12:45-14:15
oom: Poster & Exhibition Area
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Background:Hantavirus pulmonary syndrome (HPS) is a health
roblem in Brazil because of encroachment of sprawling urban,
gricultural, and cattle-raising areas into habitats of subfamily Sig-
odontinae rodents, which serve as hantavirus reservoirs. From
993 thru 2012, ∼1450 cases of HPS with a case-fatality rate of
9% were reported in Brazil. A large amount of these cases were
aused by Araraquara virus (ARAV) harbored by Necromys lasiurus,
rodent that lives in cerrado (a savanna-like ecosystem) regions at
he southeastern and central plateau of Brazil.
Methods: This study included: analisys of HPSP patients,
urveillance for hantavirus infections in wild rodents, experimen-
al Necromys lasiurus infection by hantavirus, analysis of HPS fatal
ases in different regions of Brazil.
Results: SeventyHPS cases fromcerrado regionpresenteddysp-
ea (87%), fever (81%), coughing (44%), headache (34%), tachycardia
81%), low arterial blood pressure (56%), metabolic acidosis (57%),
ymphocytopenia (51%), hematocrit >45% (70%), leukocytosis with
eft deviation (67%), creatinine (51%) and urea (42%). Respiratory
nsufﬁciency, low arterial blood pressure and shock occurred after
4 to 48 hours after starting symptoms. The case fatality rate was
4.3%. High hematocrit and decreased platelet levels were signs
trongly suggestive of the disease. We have also captured 568
odents in cerrado area, Necromys lasiurus was the most abundant,
nd 12.2% of these animals had antibodies to hantavirus. There-
ore, onlyARAVwas detected infectingNecromys.Necromys lasiurus
xperimentally inoculated with Rio Mamore hantavirus (RMV- not
elated to human disease), by intradermic route, produced virus
nfection andRMVwas recovered from lung, heart, spleen, liver and
idney. Besides, the infected Necromys lasiurus started to eliminate
MV in the urine 3 days and in the feces 6 days after inoculation.
he animals eliminated virus in the excreta for at least 14 days,
uggesting that Necromys lasiurus is able to transmit hantavirus.nfectious Diseases 16S (2012) e2–e157
Conclusion: Seventy percent of Brazilian HPS cases occured in
Southern, South-Eastern andCentral-Plateau regions.However, the
case-fatality rate of HPS was signiﬁcantly higher in cerrado areas
of South-Eastern and Central-Plateau. ARAV causes severe HPS that
leads to the highest case-fatality rate in the Americas. Therefore,
ARAV is, probably, themost virulent among all hantavirusesworld-
wide.
http://dx.doi.org/10.1016/j.ijid.2012.05.196
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A shorter time interval between ﬁrst and second dengue infec-
tions is associated with protection from clinical illness in a
prospective school-based cohort in Thailand
K. Anderson1, R.V. Gibbons2,∗, A.L. Rothman3, R. Berkelman4, T.P.
Endy5
1 Rollins School of Public Health, Atlanta, GA, USA
2 Armed Forces Research Institute of Medical Sciences, Bangkok,
Thailand
3 University of Rhode Island, Providence, RI, USA
4 Rollins School of Public Health, Atlanta, GA, USA
5 State University of New York at Syracuse, Syracuse, NY, USA
Background:Despite the strong associationbetween secondary
dengue (DENV) infections and dengue hemorrhagic fever (DHF),
the majority of secondary infections are asymptomatic or dengue
fever (DF). The determinants of the clinical severity of secondary
infections remain unclear, though some studies have suggested
a possible titer-dependent and time-dependent role of cross-
protective dengueDENV antibodies.We investigate the association
between the time interval separating sequential DENV infections
and clinical severity andwhether, among individualswith the same
interval between infections, there were immunological differences
that were associated with disease severity.
Methods:Weuseddata from twophases of a prospective cohort
study to detect asymptomatic and symptomatic DENV infections
in school-children in Kamphaeng Phet, Thailand, conducted from
1998 to 2002 and 2004 to 2007. Children who experienced at least
one DENV infection during their enrollment were selected as the
population for analysis.
Results: 1696 children had at least one DENV infection detected
during their enrollment and 268 of these children had two DENV
infections detected. A shorter time interval between the ﬁrst and
second DENV infections detected in the cohort was associated with
an increased probability of asymptomatic infection. The associa-
tion was strongest in children who were seronegative for DENV-1
– DENV-4 by hemagglutination inhibition (HI) assay at enrollment
(average interval separating sequential infections of 2.6 years for
DHF, 1.9 years for DF, and 1.6 years for asymptomatic infections,
p=0.01 by exact Wilcoxon rank statistic). In the ﬁnal model com-
bining time since ﬁrst observed infection and the magnitude of
the antibody response to ﬁrst infection, the highest probability of
being asymptomatic was observed in individuals who experienced
their second infection at shorter intervals after the ﬁrst infection
and with a higher titer HI antibody response generated to the ﬁrst
infection.
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Conclusion: These ﬁndings are consistent with a tempo-
al/immunological model of disease risk where cross-reactive
ntibodies wane from higher-titer, protective levels to lower-titer,
etrimental levels. This is the ﬁrst time that a temporarywindowof
ross-protection following DENV infection has been demonstrated
sing human infection data since early observations from human
hallenge studies in the 1940s.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.197
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eroprevalence of poliovirus antibodies amongst children in
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Background: Poliomyelitis is endemic in Northern Nigeria,
here there is continuous transmission of wild poliovirus 1 and
and circulating vaccine derived poliovirus 2 , resulting in a high
umber of cases of children with acute ﬂaccid paralysis. The sero-
revalence of antibodies to polio serotypes which assesses the
mmune status and vaccine effectiveness against poliomyelitis is
nknown, despite its endemicity in this part of the world.
Methods:Adescriptive, cross sectional, community based study
as undertaken in Zaria, North Western Nigeria between 2008 and
009. Two hundred and sixty-four (264) children aged 1-10 years
ere enrolled from two local governments in Zaria by multistage
andom sampling method. Demographic data and polio immu-
ization history were retrieved from parents and caregivers by
n interviewer administered questionnaire. Neutralising antibody
itres to polioserotypes I, II and III were assayed according to the
HO Manual for the virological investigation of polio. Antibody
itres > 1:8 was considered positive
Results:Boysmade up 60.2% of the 264 children studied and the
ean age was 6.25 years.Out of the 264 children, 173(65.5%) were
artially immunized against polio, 75(28.4%) were fully immu-
ized while 16(6.1%) had never been immunized. Seropositivity
o all polio serotypes was 55.3% while (86.4%, 76.1% and 77.3%
f children were seropositve to the P1, P2 and P3 polioserotypes
espectively). Five(1.9%) of the children had no antibodies to all the
hree polioserotypes. The lowest titres were found in children aged
–5 years-old who had lower polio antibody seroprevalence and
ntibody titres compared to children aged 6–10 years-old. Polio
ntibody seropositivity was signiﬁcantly associated with higher
ocioeconomic status as reﬂected by fathers education and immu-
ization status was the single most important determinant of
eropositivity to poliovirus serotypes.nfectious Diseases 16S (2012) e2–e157 e83
Conclusion: Compared to ﬁndings in the developed world, our
data showed a lower seroprevalence to polio virus serotypes, but
which was higher than the values found in previous studies done
in Nigeria. The use of more immunogenic vaccines together with
further improvements in programme quality and sustained sup-
port by traditional, religious and political leaders could provide the
necessary immune booster to make polio eradication in Nigeria a
reality.
http://dx.doi.org/10.1016/j.ijid.2012.05.198
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Molecular studies on psittacine beak and feather disease virus
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Background: Psittacine beak and feather disease (PBFD) is a
contagious, fatal viral disease that affects the beak, feathers, and
immune systemofwild and captiveOld andNewWorldpsittacines.
The disease is caused by a member of the genus circovirus in
the family Circoviridae, Psittacine beak and feather disease virus
(PBFDV).
Methods: Polymerase chain reaction (PCR) is the most reliable
means of conﬁrming the presence of the PBFDV ambisence DNA
genome in whole blood or tissue samples. We used an established
PCR assay (Ritchie et al., 2004) to investigate the presence of PBFDV
replicase-associated protein (Rep) gene in samples collected from
bird farms, bird markets, and veterinary clinics in the Kingdom of
Saudi Arabia (KSA). Sampleswere collected fromclinically-suspect,
and apparently-normal birds. PBFDV was identiﬁed for the ﬁrst
time in the KSA. The virus was diagnosed in clinically-suspect birds
from Al-ahsa bird market, Alqatif private farm, and the veterinary
clinic at the College of Veterinary Medicine and Animal Resources,
KFU.
